Cargando…

Breaking down walls in prostate cancer with the MURAL collection of patient-derived xenografts

A bank of 59 well-characterised prostate cancer patient-derived xenografts was established, including 17 classed as research-ready covering the disease-spectrum which, plus associated resources (organoids, serum, DNA/RNA profiles, tissue), are available for collaborative projects. This eagerly-antic...

Descripción completa

Detalles Bibliográficos
Autor principal: Bevan, Charlotte L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8448875/
https://www.ncbi.nlm.nih.gov/pubmed/34535657
http://dx.doi.org/10.1038/s41467-021-25783-1
_version_ 1784569329737531392
author Bevan, Charlotte L.
author_facet Bevan, Charlotte L.
author_sort Bevan, Charlotte L.
collection PubMed
description A bank of 59 well-characterised prostate cancer patient-derived xenografts was established, including 17 classed as research-ready covering the disease-spectrum which, plus associated resources (organoids, serum, DNA/RNA profiles, tissue), are available for collaborative projects. This eagerly-anticipated resource will facilitate pre-clinical prostate cancer therapy studies.
format Online
Article
Text
id pubmed-8448875
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-84488752021-10-05 Breaking down walls in prostate cancer with the MURAL collection of patient-derived xenografts Bevan, Charlotte L. Nat Commun Comment A bank of 59 well-characterised prostate cancer patient-derived xenografts was established, including 17 classed as research-ready covering the disease-spectrum which, plus associated resources (organoids, serum, DNA/RNA profiles, tissue), are available for collaborative projects. This eagerly-anticipated resource will facilitate pre-clinical prostate cancer therapy studies. Nature Publishing Group UK 2021-09-17 /pmc/articles/PMC8448875/ /pubmed/34535657 http://dx.doi.org/10.1038/s41467-021-25783-1 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Comment
Bevan, Charlotte L.
Breaking down walls in prostate cancer with the MURAL collection of patient-derived xenografts
title Breaking down walls in prostate cancer with the MURAL collection of patient-derived xenografts
title_full Breaking down walls in prostate cancer with the MURAL collection of patient-derived xenografts
title_fullStr Breaking down walls in prostate cancer with the MURAL collection of patient-derived xenografts
title_full_unstemmed Breaking down walls in prostate cancer with the MURAL collection of patient-derived xenografts
title_short Breaking down walls in prostate cancer with the MURAL collection of patient-derived xenografts
title_sort breaking down walls in prostate cancer with the mural collection of patient-derived xenografts
topic Comment
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8448875/
https://www.ncbi.nlm.nih.gov/pubmed/34535657
http://dx.doi.org/10.1038/s41467-021-25783-1
work_keys_str_mv AT bevancharlottel breakingdownwallsinprostatecancerwiththemuralcollectionofpatientderivedxenografts